vs
IMPINJ INC（PI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
IMPINJ INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$74.3M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 11.2%，领先372.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -0.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -14.9%）
Impinj Inc.是一家美国射频识别（RFID）设备及软件提供商，成立于2000年，总部位于华盛顿州西雅图，源自加州理工学院Carver Mead与Chris Diorio的研究成果。公司主营EPC Class 1 Gen 2无源超高频RFID芯片、读写器、读写器芯片、天线，以及芯片编码、业务数据采集相关的软件应用，为各行业RFID应用提供全链路产品支持。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PI vs RIGL — 直观对比
营收规模更大
PI
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出21.2%
-0.0%
净利率更高
RIGL
高出372.8%
11.2%
两年增速更快
RIGL
近两年复合增速
-14.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $74.3M | $69.8M |
| 净利润 | $8.3M | $268.1M |
| 毛利率 | 49.1% | 91.5% |
| 营业利润率 | 30.5% | 33.2% |
| 净利率 | 11.2% | 384.0% |
| 营收同比 | -0.0% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.14 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PIRIGL
| Q1 26 | $74.3M | — | ||
| Q4 25 | $92.8M | $69.8M | ||
| Q3 25 | $96.1M | $69.5M | ||
| Q2 25 | $97.9M | $101.7M | ||
| Q1 25 | $74.3M | $53.3M | ||
| Q4 24 | $91.6M | $57.6M | ||
| Q3 24 | $95.2M | $55.3M | ||
| Q2 24 | $102.5M | $36.8M |
净利润PIRIGL
| Q1 26 | $8.3M | — | ||
| Q4 25 | $-1.1M | $268.1M | ||
| Q3 25 | $-12.8M | $27.9M | ||
| Q2 25 | $11.6M | $59.6M | ||
| Q1 25 | $-8.5M | $11.4M | ||
| Q4 24 | $-2.7M | $14.3M | ||
| Q3 24 | $221.0K | $12.4M | ||
| Q2 24 | $10.0M | $-1.0M |
毛利率PIRIGL
| Q1 26 | 49.1% | — | ||
| Q4 25 | 51.8% | 91.5% | ||
| Q3 25 | 50.3% | 93.2% | ||
| Q2 25 | 57.8% | 95.6% | ||
| Q1 25 | 49.4% | 91.7% | ||
| Q4 24 | 50.5% | 89.9% | ||
| Q3 24 | 50.0% | 85.5% | ||
| Q2 24 | 56.1% | 92.4% |
营业利润率PIRIGL
| Q1 26 | 30.5% | — | ||
| Q4 25 | -2.9% | 33.2% | ||
| Q3 25 | 0.7% | 40.9% | ||
| Q2 25 | 11.1% | 60.1% | ||
| Q1 25 | -12.9% | 23.9% | ||
| Q4 24 | -3.9% | 28.9% | ||
| Q3 24 | -0.8% | 25.4% | ||
| Q2 24 | 8.8% | 1.2% |
净利率PIRIGL
| Q1 26 | 11.2% | — | ||
| Q4 25 | -1.2% | 384.0% | ||
| Q3 25 | -13.3% | 40.2% | ||
| Q2 25 | 11.8% | 58.6% | ||
| Q1 25 | -11.4% | 21.5% | ||
| Q4 24 | -2.9% | 24.9% | ||
| Q3 24 | 0.2% | 22.5% | ||
| Q2 24 | 9.7% | -2.8% |
每股收益（稀释后）PIRIGL
| Q1 26 | $0.14 | — | ||
| Q4 25 | $-0.02 | $14.11 | ||
| Q3 25 | $-0.44 | $1.46 | ||
| Q2 25 | $0.39 | $3.28 | ||
| Q1 25 | $-0.30 | $0.63 | ||
| Q4 24 | $-0.06 | $0.82 | ||
| Q3 24 | $0.01 | $0.70 | ||
| Q2 24 | $0.34 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $131.8M | $155.0M |
| 总债务越低越好 | $241.5M | $52.5M |
| 股东权益账面价值 | — | $391.5M |
| 总资产 | $502.5M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PIRIGL
| Q1 26 | $131.8M | — | ||
| Q4 25 | $175.3M | $155.0M | ||
| Q3 25 | $190.1M | $137.1M | ||
| Q2 25 | $193.2M | $108.4M | ||
| Q1 25 | $147.9M | $77.1M | ||
| Q4 24 | $164.7M | $77.3M | ||
| Q3 24 | $170.3M | $61.1M | ||
| Q2 24 | $220.2M | $49.1M |
总债务PIRIGL
| Q1 26 | $241.5M | — | ||
| Q4 25 | $280.9M | $52.5M | ||
| Q3 25 | $280.4M | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $283.5M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益PIRIGL
| Q1 26 | — | — | ||
| Q4 25 | $209.2M | $391.5M | ||
| Q3 25 | $195.0M | $117.6M | ||
| Q2 25 | $187.7M | $81.9M | ||
| Q1 25 | $160.6M | $18.6M | ||
| Q4 24 | $149.9M | $3.3M | ||
| Q3 24 | $136.1M | $-14.6M | ||
| Q2 24 | $117.0M | $-29.9M |
总资产PIRIGL
| Q1 26 | $502.5M | — | ||
| Q4 25 | $545.2M | $513.6M | ||
| Q3 25 | $516.5M | $242.5M | ||
| Q2 25 | $508.8M | $206.7M | ||
| Q1 25 | $479.8M | $176.0M | ||
| Q4 24 | $489.1M | $164.0M | ||
| Q3 24 | $476.4M | $139.4M | ||
| Q2 24 | $446.1M | $128.4M |
负债/权益比PIRIGL
| Q1 26 | — | — | ||
| Q4 25 | 1.34× | 0.13× | ||
| Q3 25 | 1.44× | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 1.89× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $2.2M | — |
| 自由现金流率自由现金流/营收 | 3.0% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $61.1M | — |
8季度趋势，按日历期对齐
经营现金流PIRIGL
| Q1 26 | — | — | ||
| Q4 25 | $15.1M | $22.0M | ||
| Q3 25 | $20.9M | $24.0M | ||
| Q2 25 | $33.9M | $30.5M | ||
| Q1 25 | $-11.1M | $-893.0K | ||
| Q4 24 | $12.6M | $14.5M | ||
| Q3 24 | $10.1M | $21.7M | ||
| Q2 24 | $45.5M | $302.0K |
自由现金流PIRIGL
| Q1 26 | $2.2M | — | ||
| Q4 25 | $13.6M | — | ||
| Q3 25 | $18.0M | — | ||
| Q2 25 | $27.3M | — | ||
| Q1 25 | $-13.0M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $4.7M | — | ||
| Q2 24 | $44.1M | — |
自由现金流率PIRIGL
| Q1 26 | 3.0% | — | ||
| Q4 25 | 14.7% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 27.9% | — | ||
| Q1 25 | -17.5% | — | ||
| Q4 24 | 9.3% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 43.0% | — |
资本支出强度PIRIGL
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 1.3% | — |
现金转化率PIRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 2.93× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 45.56× | 1.75× | ||
| Q2 24 | 4.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
